BCLS Fund III Investments, LP - 30 Jun 2025 SCHEDULE 13G/A Report for DIANTHUS THERAPEUTICS, INC. Common Stock, $0.001 par value per share (DNTH)

Filing Manager: BCLS Fund III Investments, LP
Reporting Manager: BCLS Fund III Investments, LP
Security: DIANTHUS THERAPEUTICS, INC. Common Stock, $0.001 par value per share
Symbol: DNTH
Shares outstanding: 33.1M shares
Disclosed Ownership: 2.48M shares
Ownership: 7.5%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 16:00:14 UTC
Date of event: 30 Jun 2025
Previous filing: 14 Feb 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BCLS Fund III Investments, LP	7.5%	2.48M	0	2.48M	/s/ Ricky Sun	Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC